dc.contributor.author | Abasi, M | |
dc.contributor.author | Lotfi, P | |
dc.contributor.author | Bazmani, A | |
dc.contributor.author | Matini, M | |
dc.contributor.author | Hajilooi, M | |
dc.date.accessioned | 2018-08-26T08:54:29Z | |
dc.date.available | 2018-08-26T08:54:29Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54146 | |
dc.description.abstract | Background: Several lines of evidence demonstrating that innate and adaptive immunity play important roles in the defense against visceral leishmaniasis (VL). A polymorphism within the Fc?RIIIB gene can lead to the expression of three variants of NA1, NA2, and the combined one (NA1/NA2) which alters affinity of IgG to its receptor. | |
dc.language.iso | English | |
dc.relation.ispartof | Iranian Red Crescent Medical Journal | |
dc.subject | Fc gamma receptor IIIb NA1 | |
dc.subject | Fc gamma receptor IIIb NA2 | |
dc.subject | immunoglobulin receptor | |
dc.subject | unclassified drug | |
dc.subject | allele | |
dc.subject | antibody titer | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | controlled study | |
dc.subject | cross-sectional study | |
dc.subject | DNA sequence | |
dc.subject | female | |
dc.subject | genetic polymorphism | |
dc.subject | genotype | |
dc.subject | human | |
dc.subject | immune response | |
dc.subject | immunofluorescence test | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | polymerase chain reaction | |
dc.subject | visceral leishmaniasis | |
dc.title | Evaluation of Fc?RIIIB-NA1/NA2 Polymorphism in Visceral Leishmaniasis | |
dc.type | Article | |
dc.citation.volume | 16 | |
dc.citation.issue | 4 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.5812/ircmj.12437 | |